​

Funding Round

Series A - Moonwalk Biosciences

Series A - Moonwalk Biosciences

Investment Firm

Overview

Moonwalk Biosciences operates a genomic medicine company that aims to provide a new class of precision epigenetic medications.

Announced Date

Jan 04, 2024

Closed on Date

Jan 04, 2024

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Alpha Wave Global

Alpha Wave Global

Alpha Wave Global is a convertible_note and debt and early_stage_venture and late_stage_venture and private_equity and seed and venture firm.

Participant Investors

5

Investor Name
Participant InvestorYK Bioventures
Participant InvestorAlpha Wave Global
Participant InvestorGoogle Ventures
Participant InvestorARCH Venture Partners
Participant InvestorKhosla Ventures

Round Details and Background

Moonwalk Biosciences raised $57000000 on 2024-01-04 in Series A

Moonwalk Biosciences operates a genomic medicine company that aims to provide a new class of precision epigenetic medications.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 04, 2024
Series A - Moonwalk Biosciences
6-57.0M
Oct 01, 2023
Seed Round - Moonwalk Biosciences
-undefined

Recent Activity

There is no recent news or activity for this profile.